Gil Labrucherie's profile picture

Gil Labrucherie

Chief Financial Officer & Chief Business Officer at ACELYRIN

Gil Labrucherie is a seasoned executive with extensive experience in the biopharmaceutical sector, currently serving as Chief Financial Officer and Chief Business Officer at ACELYRIN, INC. since August 2023. Previously, Gil held various leadership roles, including Chief Financial Officer and Chief Operating Officer at Nektar Therapeutics, where responsibilities encompassed financial planning, strategic development, and investor relations. Gil also serves as Managing Trustee of the Bloom Family Trust and as a board member for Rezolute, Inc. and has participated on the board for Valinor Pharma until its acquisition in July 2024. Educational credentials include a Juris Doctor from the University of California, Berkeley - School of Law and a Bachelor of Arts with Highest Honors from the University of California, Davis.

Links

Previous companies

Nektar Therapeutics logo
E2open logo


Teams

This person is not in any teams


  1. This content will be removed shortly.